Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide (2022)
- Authors:
- USP affiliated authors: LOPES, LUCIANA BIAGINI - ICB ; APOLINÁRIO, ALEXSANDRA CONCEIÇÃO - ICB ; SALATA, GIOVANNA CASSONE - ICB
- Unidade: ICB
- DOI: 10.1208/s12249-022-02257-1
- Subjects: FARMACOLOGIA; GEL (FORMAS FARMACÊUTICAS); MEDICAMENTO; NANOTECNOLOGIA; QUIMIOTERÁPICOS; ANTINEOPLÁSICOS; NEOPLASIAS MAMÁRIAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: AAPS PharmSciTech
- ISSN: 1530-9932
- Volume/Número/Paginação/Ano: v. 23, art. 104, p. 1-14, 2022
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
APOLINÁRIO, Alexsandra Conceição et al. Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide. AAPS PharmSciTech, v. 23, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.1208/s12249-022-02257-1. Acesso em: 18 maio 2025. -
APA
Apolinário, A. C., Salata, G. C., Souza, M. M. de, Chorilli, M., & Lopes, L. B. (2022). Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide. AAPS PharmSciTech, 23, 1-14. doi:10.1208/s12249-022-02257-1 -
NLM
Apolinário AC, Salata GC, Souza MM de, Chorilli M, Lopes LB. Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide [Internet]. AAPS PharmSciTech. 2022 ; 23 1-14.[citado 2025 maio 18 ] Available from: https://doi.org/10.1208/s12249-022-02257-1 -
Vancouver
Apolinário AC, Salata GC, Souza MM de, Chorilli M, Lopes LB. Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide [Internet]. AAPS PharmSciTech. 2022 ; 23 1-14.[citado 2025 maio 18 ] Available from: https://doi.org/10.1208/s12249-022-02257-1 - Optimization of nanoemulsified systems containing lamellar phases for co-delivery of celecoxib and endoxifen to the skin aiming for breast cancer chemoprevention and treatment
- Abrindo a caixa de pandora dos nanomedicamentos: há realmente muito mais ‘espaço lá embaixo’
- Phosphatidylcholine-based nanoemulsions for paclitaxel and a P-Glycoprotein inhibitor delivery and breast cancer intraductal treatment
- Novel lipid nanovesicle-loaded dissolving microarray patches for fenretinide in breast cancer chemoprevention
- A lipid-based in situ-forming hexagonal phase for prolonged retention and drug release in the breast tissue
- Lipid nanovesicles for biomedical applications: ‘what is in a name’?
- Towards nanoformulations for skin delivery of poorly soluble API: What does indeed matter?
- Monoolein-based nanodispersions for cutaneous co-delivery of methylene blue and metformin: thermal and structural characterization and effects on the cutaneous barrier, skin penetration and cytotoxicity
- Design of multifunctional ethosomes for topical fenretinide delivery and breast cancer chemoprevention
- Topical transdermal chemoprevention of breast cancer: where will nanomedical approaches deliver us?
Informações sobre o DOI: 10.1208/s12249-022-02257-1 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
